Self-Monitoring Blood Glucose (SMBG) Device Market is expected to cross over US$ 16 Billion by 2020 as incidence of diabetes is increasing dramatically. It is estimated that 642 Million people will develop the disease by 2040. This is putting pressure on governments and social institutions to take necessary steps to keep the disease in check and avoid complications in order to ensure that diabetic impact is kept to a minimum. United States is the single largest market for SMBG devices market followed by Russia and United Kingdom. However, China has the highest self-monitoring of blood glucose users compared to other countries.
United States, Russia and United Kingdom together hold more than 63 percent of the total test strips market share whereas in blood glucose meter market China is the dominating country. All big players such as Roche, Bayer and Abbott Laboratories are continuously losing their market share.
“Blood Glucose Device Market & Forecast (SMBG) (Test Strips, Lancet, Meter) – Worldwide Analysis” analyzes the worldwide market for, blood glucose test strips market, blood glucose lancet market and blood glucose meter market. This is the 3rd publication on Glucose Device Market by Renub Research. This report studies separate comprehensive analytics for the 15 countries: United States, European Countries (United Kingdom, Germany, Spain, Italy, Netherlands, Norway, Sweden and Switzerland), BRIC countries (Brazil, Russia, India, China), Australia and Kuwait. Annual estimates and forecast are provided for the period of 2016 through 2020. A nine year historic analysis is also provided for these markets. This 269 page report with 257 Figures and 12 Tables provides a complete analysis of top 15 countries of worldwide self-monitoring blood glucose (SMBG) market.
Test Strip, Lancet, Glucose Meter Market, Diabetes Population of 15 Countries covered as follows
- Diabetes Population Scenario and Forecast in all 15 countries - Type 1 and Type 2 Diabetes Scenario and Forecast in all 15 countries - Self-Monitoring Blood Glucose (SMBG) Devices Users and Forecast in all 15 countries - Self-Monitoring Blood Glucose Devices (SMBG) Market and Forecast in all 15 countries - Blood Glucose Test Strips Market and Forecast in all 15 countries - Blood Glucose Lancet Market and Forecast in all 15 countries - Blood Glucose Meter Market and Forecast in all 15 countries
Countries Covered in this Report:
1. United States 2. United Kingdom 3. Germany 4. Spain 5. Italy 6. Netherlands 7. Norway 8. Sweden 9. Switzerland 10. Brazil 11. Russia 12. India 13. China 14. Australia 15. Kuwait
4 Companies Revenue (Sales) from Self-Monitoring Blood Glucose (SMBG) devices have been analyzed in this report.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts.
Primary sources include industry surveys and telephonic interviews with industry experts.
Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.
Our reports have been used by over 10K customers, including:
The global remote patient monitoring market is expected to reach US$ 7,338.92 million by 2028 from US$ 2,177.69 million in 2020. The market is estimated to grow at a CAGR of 16.4% during 2020-2028. The key factors that are driving the growth of market are the growing prevalence of chronic diseases, rising awareness regarding healthcare, and...
The patient monitoring devices market is projected to reach USD 55.1 billion by 2025 from USD 36.4 billion in 2020, at a CAGR of 8.6% during the forecast period. Growth of the market is mainly attributed to the technological advancements; increasing incidences of infectious diseases, and growing public and private investments, funding, and...
The global remote patient monitoring market is projected to reach USD 117.1 billion by 2025 from USD 23.2 billion in 2020, at a CAGR of 38.2% between 2020 and 2025. The rising geriatric population and the growing need to expand healthcare access, cost benefits of telehealth and remote patient monitoring, benefits of RPM to reduce the burden...
The Global Remote Patient Monitoring market is expected to reach US$ 1,544.94 Mn in 2027 from US$ 712.21 Mn in 2018. The market is estimated to grow with a CAGR of 9.3% from 2019-2027. The growth of the Remote Patient Monitoring market is primarily attributed to the factors such as increasing prevalence of chronic diseases, rising geriatric...
Chronic Disease Prevalence
Medical Technology Density
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.